A review on the development of gold-based compounds as aquaglyceroporin inhibitors with potential as therapeutic agents or as chemical probes.
No takes yet. Share an insight, caveat, or question.
Almeida et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: